In this way, dendritic cells present the telomerase antigen epitopes in a MHC class I or II to CD8+ T or helper CD4+ T lymphocytes, boosting durable and specific immune responses against leukemia cells (Figure 4) [237,238,263,264]. The gene discussed is CD8A; the disease is leukemia.